| Kalgoorlie Gold Mining Limited (KAL) ORDINARY FULLY PAID |
Materials |
$21 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Apr 2025 9:11AM |
$0.044 |
$0.046 |
risen by
5.75%
|
|
KAL - Price-sensitive ASX Announcement
Full Release
Key Points
- KAL continued exploration activities at its Bulong Taurus Gold Project during the March 2023 quarter.
- The company focused on reverse circulation (RC) drilling at the La Mascotte prospect, reporting significant gold intercepts.
- Additional soil sampling and geological mapping were undertaken across the Bulong Taurus tenements.
- KAL reviewed historical data and undertook planning for further exploration at other prospects, including Great Ophir, Torquay, and Red White and Blue.
- The company progressed heritage engagement with the Marlinyu Ghoorlie Native Title Claim Group, with on-country heritage surveys completed.
- No mining production or development activities were undertaken during the quarter.
- KAL maintained a strong cash position, ending the quarter with approximately $3.0 million cash on hand.
- Expenditure during the quarter was primarily on exploration, tenement holding costs, and administration.
- The company continues to assess acquisition and joint venture opportunities in the Western Australian goldfields.
- KAL is committed to responsible exploration and engaging with relevant stakeholders, including traditional owners and regulatory bodies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| One Click Group Limited (1CG) ORDINARY FULLY PAID |
Industrials |
$14 |
Notice of Annual General Meeting/Proxy Form
|
30 Apr 2025 9:10AM |
$0.008 |
$0.011 |
risen by
37.50%
|
|
| European Lithium Limited (EUR) ORDINARY FULLY PAID |
Materials |
$292 |
Quarterly Activities Report and Appendix 5B
|
30 Apr 2025 9:10AM |
$0.051 |
$0.170 |
risen by
233.33%
|
|
EUR - Price-sensitive ASX Announcement
Full Release
Key Points
- Wolfsberg Lithium Project in Austria continued development with focus on definitive feasibility study (DFS) and permitting.
- Progress made on environmental and legal matters at the project site.
- Corporate update on planned NASDAQ listing via merger with Sizzle Acquisition Corp and formation of Critical Metals Corp.
- Expected completion of business combination and NASDAQ listing during the September 2023 quarter.
- Financial updates provided, including net operating cash outflows of AU$1.188 million and cash at quarter end of AU$6.608 million.
- Receipt of research and development tax incentive refund of AU$1.115 million during the quarter.
- Disclosure of payments to related parties and their associates as required.
- Ongoing stakeholder engagement and project milestone planning.
- Appendix 5B satisfies ASX financial reporting requirements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Optiscan Imaging Limited (OIL) ORDINARY FULLY PAID |
Health Care |
$104 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Apr 2025 9:10AM |
$0.135 |
$0.100 |
fallen by
25.93%
|
|
OIL - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarter ended 31 December 2023 covered
- Progress made towards clinical adoption and commercialization of imaging technology
- Submission of regulatory filings and work on FDA clearance for InVivage®
- Ongoing product development and enhancements for clinical applications
- Partnerships advanced with organizations such as Mayo Clinic and Australian National Fabrication Facility
- Participation in industry conferences and events to drive awareness and adoption
- Cash balance of $10.97 million as of 31 December 2023
- Net cash used in operating activities was $2.69 million for the quarter
- Strategic focus remains on regulatory approvals, commercial partnerships, and expanding clinical reach
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Jupiter Mines Limited. (JMS) ORDINARY FULLY PAID |
Materials |
$540 |
Q3 FY2025 Quarterly Activities Report
|
30 Apr 2025 9:09AM |
$0.150 |
$0.275 |
risen by
83.33%
|
|
JMS - Price-sensitive ASX Announcement
Full Release
Key Points
- Tshipi Borwa Manganese Mine continued production with a focus on safety and efficiency.
- Manganese market faced price volatility, impacting revenues.
- Operational cost-saving measures were implemented to maintain margins.
- Sales volumes were affected by global market demand and logistics challenges.
- Capital projects and maintenance initiatives progressed as planned.
- Strong emphasis on health and safety, with continued improvements recorded.
- Community engagement and sustainability initiatives were ongoing.
- Company remains vigilant and adaptive to changing market conditions.
- Future outlook discusses focus on operational excellence and long-term growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ventia Services Group Limited (VNT) ORDINARY FULLY PAID |
Industrials |
$4,966 |
Update - Notification of buy-back - VNT
|
30 Apr 2025 9:09AM |
$4.220 |
$6.000 |
risen by
42.18%
|
|
| Aldoro Resources Ltd (ARN) ORDINARY FULLY PAID |
Materials |
$85 |
Reinstatement to Quotation
|
30 Apr 2025 9:08AM |
$0.520 |
$0.375 |
fallen by
27.88%
|
|
ARN - Price-sensitive ASX Announcement
Full Release
Key Points
- Aldoro Resources Ltd shares reinstated to official quotation on ASX.
- Suspension was lifted after the company met ASX compliance requirements.
- All necessary documentation and confirmations were submitted to ASX.
- Resumption of trading effective from 10:15 AM AEST on 5 June 2024.
- Company confirmed compliance with all listing rules and relevant regulations.
- Background and procedural steps for reinstatement are outlined in the announcement.
- Reinstatement follows a period of suspension related to specific ASX requirements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aldoro Resources Ltd (ARN) ORDINARY FULLY PAID |
Materials |
$85 |
Response to ASX Price Query
|
30 Apr 2025 9:08AM |
$0.520 |
$0.375 |
fallen by
27.88%
|
|
ARN - Price-sensitive ASX Announcement
Full Release
Key Points
- Aldoro Resources Ltd addressed an ASX Price Query on recent share price and volume changes.
- The company stated it is not aware of any undisclosed information that could account for the market movement.
- Aldoro Resources confirmed its commitment to continuous disclosure obligations under ASX listing rules.
- The company referenced ongoing exploration activities, particularly at the Niobe project.
- All material information about exploration results and activities has already been released to the market.
- The Board authorized the lodgement and release of the response to the ASX.
- The announcement date is 23 June 2022.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aldoro Resources Ltd (ARN) ORDINARY FULLY PAID |
Materials |
$85 |
Potential Tier 1 Strategic Metal Discovery At Kameelburg
|
30 Apr 2025 9:08AM |
$0.520 |
$0.375 |
fallen by
27.88%
|
|
ARN - Price-sensitive ASX Announcement
Full Release
Key Points
- Aldoro Resources Ltd announced significant results from the Kameelburg project.
- Spodumene-rich pegmatite zones have been identified, indicating lithium mineralization.
- Ongoing drilling and geophysical surveys confirm potential for high-grade lithium deposits.
- The discovery is considered to have Tier 1 strategic metal potential.
- The project is of strategic importance for both Aldoro and the broader lithium market.
- Next steps include further drilling, mapping, and resource estimation.
- The announcement received strong support from stakeholders and the investment community.
- Aldoro Resources is committed to advancing the Kameelburg project to deliver shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orthocell Limited (OCC) ORDINARY FULLY PAID |
Health Care |
$285 |
Remplir Approved to Commence Sales in US$75m Canadian Market
|
30 Apr 2025 9:08AM |
$1.465 |
$1.050 |
fallen by
28.33%
|
|
OCC - Price-sensitive ASX Announcement
Full Release
Key Points
- Orthocell Limited received approval to commence sales of Remplir in Canada.
- The Canadian market for Remplir is estimated to be worth US$75 million.
- Remplir is a device used in peripheral nerve repair procedures.
- This approval is a key milestone in Orthocell's global expansion strategy.
- Orthocell is focused on delivering innovative solutions for nerve repair.
- The company continues to pursue additional regulatory and commercial opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Carlton Investments Limited (CIN) ORDINARY FULLY PAID |
Financials |
$923 |
Daily share buy-back notice - Appendix 3E
|
30 Apr 2025 9:07AM |
$32.020 |
$35.000 |
risen by
9.31%
|
|
| Northern Minerals Limited (NTU) ORDINARY FULLY PAID |
Materials |
$286 |
Quarterly Activities Report
|
30 Apr 2025 9:07AM |
$0.034 |
$0.030 |
fallen by
11.76%
|
|
NTU - Price-sensitive ASX Announcement
Full Release
Key Points
- Continued development and technical optimization at the Browns Range Project in Western Australia.
- Ongoing pilot plant operations and metallurgical testwork to improve processing and recovery methods.
- Updates on exploration programs aimed at expanding resource estimates and extending project life.
- Financial summary indicating cash balances, quarterly expenditure, and cost management strategies.
- Engagement with potential strategic partners and stakeholders to support project advancement.
- Regulatory compliance, environmental responsibility, and community relations remain priorities.
- Forward-looking statements on project milestones, operational targets, and funding strategies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Jade Gas Holdings Limited (JGH) ORDINARY FULLY PAID |
Energy |
$63 |
Quarterly Activities Report & Appendix 5B
|
30 Apr 2025 9:07AM |
$0.037 |
$0.034 |
fallen by
8.11%
|
|
JGH - Price-sensitive ASX Announcement
Full Release
Key Points
- Progress reported at TTCBM Project in Mongolia, focusing on pilot well performance and gas production rates.
- Resource evaluations and technical studies continue to advance.
- Active engagement with Mongolian authorities and local communities.
- Exploration activities and resource certification updates provided.
- Financial highlights include details on cash flows, investments, and quarterly expenditure.
- Planned activities for upcoming quarters include additional drilling and pilot production expansion.
- Strategic partnerships and stakeholder engagement remain a focus.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AnteoTech Limited (ADO) ORDINARY FULLY PAID |
Materials |
$46 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Apr 2025 9:06AM |
$0.009 |
$0.017 |
risen by
88.89%
|
|
ADO - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities and Appendix 4C Cash Flow Report released for Q1 2024.
- Completed acquisition of MyHealthTest, expanding diagnostics capabilities.
- Finalized development and started commercial sales of X-ONE Bead products.
- Progress in AnteoCoat's silicon anode technology for batteries, with ongoing customer testing and scale-up.
- Reported $0.4 million in customer receipts and a net operating cash outflow of $2.7 million.
- Cash balance at quarter end was $5.2 million with an additional $2.0 million in available facilities.
- Focused on commercializing advanced materials and diagnostics technologies.
- Strengthened global partnerships and continued disciplined cost management.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Actinogen Medical Limited (ACW) ORDINARY FULLY PAID |
Health Care |
$188 |
Actinogen March 2025 quarterly activity report & Appendix 4C
|
30 Apr 2025 9:05AM |
$0.026 |
$0.059 |
risen by
126.92%
|
|
ACW - Price-sensitive ASX Announcement
Full Release
Key Points
- Progress in Xanamem clinical trials targeting cognitive decline in Alzheimer's and major depressive disorder.
- Positive interactions with global regulatory agencies to support clinical and commercial strategy.
- Ongoing business development discussions with potential commercial and strategic partners.
- Detailed quarterly cash flow statements and financial overview, including R&D expenses.
- Strong cash position reported at the end of the quarter.
- Overview of shareholder and investor engagement activities.
- Clear outline of upcoming milestones and strategic priorities for future quarters.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Percheron Therapeutics Limited (PER) ORDINARY FULLY PAID |
Health Care |
$9 |
Quarterly Activities Report and Appendix 4C
|
30 Apr 2025 9:04AM |
$0.010 |
$0.009 |
fallen by
15%
|
|
PER - Price-sensitive ASX Announcement
Full Release
Key Points
- PER-001 program advanced towards the final preclinical development stages.
- Significant progress in manufacturing activities for PER product candidates.
- New intellectual property secured during the quarter.
- Active engagement with strategic partners and potential investors.
- Comprehensive financial update provided, including cash flows and R&D expenditure.
- Company remains focused on progressing therapeutic programs and maintaining financial stability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Syntara Limited (SNT) ORDINARY FULLY PAID |
Health Care |
$52 |
Quarterly Activities Report
|
30 Apr 2025 9:03AM |
$0.053 |
$0.032 |
fallen by
39.62%
|
|
SNT - Price-sensitive ASX Announcement
Full Release
Key Points
- Progression of core technology and product development initiatives.
- Ongoing engagement and partnership discussions with commercial entities.
- Financial highlights, including cash flow and R&D expenditure.
- Compliance with ASX listing requirements and relevant regulations.
- Updates on intellectual property protection and patent filings.
- Notable management and operational changes during the quarter.
- Commitment to innovation and long-term business objectives.
- Detailed review of customer engagement and partnership outcomes.
- Strategic investments in research, staff, and product commercialization.
- Outlook and ongoing priorities for the next reporting period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Arika Resources Limited (ARI) ORDINARY FULLY PAID |
Materials |
$35 |
Trading Halt
|
30 Apr 2025 9:03AM |
$0.027 |
$0.031 |
risen by
14.81%
|
|
ARI - Price-sensitive ASX Announcement
Full Release
Key Points
- Arika Resources Limited (ARI) requested a trading halt on 27 March 2024.
- The trading halt is related to a pending capital raising announcement.
- The halt is to ensure fair disclosure and prevent trading on incomplete information.
- Trading of ARI securities will resume either after the announcement or by 29 March 2024.
- ARI has confirmed compliance with ASX Listing Rules.
- The market will be notified as soon as the announcement is ready.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Waratah Minerals Limited (WTM) ORDINARY FULLY PAID |
Materials |
$173 |
Quarterly Activities Report - March 2025
|
30 Apr 2025 9:03AM |
$0.200 |
$0.560 |
risen by
180%
|
|
WTM - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report for the period ended 31 March 2025.
- Exploration activities focused on the Mt Carrington gold-silver project and other assets.
- Progress on drilling programs, resource definition, and development planning.
- Health, safety, and environmental performance maintained at high standards.
- Financial update provided, including cash flow details and funding status.
- Operational milestones achieved and ongoing steps towards project advancement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AustChina Holdings Limited (AUH) ORDINARY FULLY PAID |
Energy |
- |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Apr 2025 9:02AM |
$0.001 |
$0.002 |
risen by
100%
|
|
AUH - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities Report and Appendix 5B Cash Flow Report for the period ended 31 March 2024.
- AustChina Holdings Limited focuses on investment in energy and resources, particularly coal exploration in Queensland.
- Continued progress on the Blackall Coal Project with ongoing exploration and stakeholder engagement.
- Maintains a minority interest in Copperstone Resources AB and considers new investment opportunities.
- Quarterly financials detail cash flows from operating, investing, and financing activities, with a maintained strong cash balance.
- Ongoing commitment to ESG responsibilities and adherence to corporate governance frameworks.
- Appendix 5B confirms sufficient funding for planned future activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Northern Minerals Limited (NTU) ORDINARY FULLY PAID |
Materials |
$286 |
Quarterly Cash Flow Report
|
30 Apr 2025 9:02AM |
$0.034 |
$0.030 |
fallen by
11.76%
|
|
NTU - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly cash flow report covers activities up to March 31, 2024.
- Continued progress at the Browns Range Project, focusing on heavy rare earths.
- Exploration, evaluation, and development expenditures detailed for the quarter.
- Disclosure of net cash used in operating, investing, and financing activities.
- Reporting on the company's cash position at the end of the reporting period.
- Update on strategies for advancing the Browns Range Project towards commercial production.
- Engagement with key stakeholders and compliance with ASX listing rules.
- Forecast of future cash outflows and project development plans.
- No significant changes in business activities outside those previously announced.
- The company remains focused on its objective to become a key supplier of heavy rare earths outside China.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Powerhouse Ventures Limited (PVL) ORDINARY FULLY PAID |
Financials |
$23 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Apr 2025 9:01AM |
$0.088 |
$0.145 |
risen by
64.77%
|
|
PVL - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers the period ending 31 March 2023.
- PVL continues to support and monitor its investment portfolio.
- Portfolio companies showed progress and positive developments.
- PVL focused on prudent cost management and operational efficiency.
- Cash at the end of the quarter was $1.37 million.
- Net cash used in operating activities was $0.16 million.
- No investments were made in new companies during the quarter.
- PVL continues to review and manage costs to preserve shareholder value.
- The company meets ASX Listing Rule 4.7C disclosures on related party payments.
- PVL remains committed to creating long-term value for shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Waratah Minerals Limited (WTM) ORDINARY FULLY PAID |
Materials |
$173 |
Quarterly Cashflow Report - March 2025
|
30 Apr 2025 9:00AM |
$0.200 |
$0.560 |
risen by
180%
|
|
WTM - Price-sensitive ASX Announcement
Full Release
Key Points
- Covers cashflows for the quarter ended March 2025
- Reports on cash in and outflows from operating, investing, and financing activities
- Exploration and evaluation expenditures were a significant part of outflows
- Details on corporate and administrative expenditure
- Includes summary of cash position at the end of the quarter
- Provides updates on exploration activities and tenement holdings
- Statement regarding compliance with ASX Listing Rules
- Contains an appendix with further mining exploration entity disclosures
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cobre Ltd (CBE) ORDINARY FULLY PAID |
Materials |
$52 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Apr 2025 9:00AM |
$0.052 |
$0.099 |
risen by
90.38%
|
|
CBE - Price-sensitive ASX Announcement
Full Release
Key Points
- Progressed copper exploration projects, mainly in the Kalahari Copper Belt, Botswana.
- Ongoing drilling and exploration at the Ngami Copper Project yielded encouraging results.
- Strategic planning for further exploration and expansion in the region.
- Maintained prudent financial management with a detailed cash flow summary.
- Sufficient cash reserves reported for ongoing and future activities.
- Continued investment in project development and exploration initiatives.
- Reaffirmed commitment to shareholder value and project advancement.
- Exploring additional opportunities within Botswana and Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Anteris Technologies Ltd (AVR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$321 |
SEC Form 10-K/A
|
30 Apr 2025 8:59AM |
$8.000 |
$7.790 |
fallen by
2.63%
|
|
AVR - Price-sensitive ASX Announcement
Full Release
Key Points
- Anteris Technologies Ltd filed an amended SEC Form 10-K/A for the fiscal year ended December 31, 2023.
- The amendment addresses corrections and additional disclosures to the original annual report.
- The company's main product is the DurAVR™ aortic valve replacement device.
- Clinical progress, trial data, and regulatory initiatives for DurAVR™ are covered.
- The report provides an in-depth management’s discussion and analysis of financial condition and results of operations.
- Key business risks include regulatory hurdles, competitive landscape, and product commercialization challenges.
- Details on legal proceedings, corporate governance, and compliance are included.
- Forward-looking statements are made regarding future performance and product development.
- The document covers the company's corporate structure, executive compensation, and director information.
- The report is intended to provide transparency and comply with SEC regulations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
